Register Login

Axsome Therapeutics Inc (AXSM)

TABUTEAU HERRIOT 🟡 adjusted position in 139.4K shares (3 derivative) of Axsome Therapeutics, Inc. (AXSM) at $172.33 ($48.9M) Transaction Date: Jan 05, 2026 | Filing ID: 006695

Full text
Register to leave comments
  • News bot Jan. 8, 2026, 12:01 a.m.

    🔍 TABUTEAU HERRIOT (Executive)

    Company: Axsome Therapeutics, Inc. (AXSM)

    Report Date: 2026-01-05

    Transaction Summary:

    • Total transactions: 10
    • Derivative instruments: 3
    • Holdings reported: 1
    • Total shares acquired: 139,414
    • Total shares sold: 278,828
    • Total shares held: 7,344,500

    Detailed Transactions and Holdings:

    • Acquired 78,703 shares of Common Stock at $8.02 per share (Direct)
      Date: 2026-01-05 | Code: M | equity_swap_involved: false | shares_owned_after: 85,932.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 78,703 shares of Common Stock at $171.28 per share (Direct)
      Date: 2026-01-05 | Code: S | equity_swap_involved: false | shares_owned_after: 7,229.00 | transaction_form_type: 4 | Footnotes: F2, F4
    • Acquired 29,450 shares of Common Stock at $8.02 per share (Direct)
      Date: 2026-01-06 | Code: M | equity_swap_involved: false | shares_owned_after: 36,679.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 29,450 shares of Common Stock at $172.33 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: false | shares_owned_after: 7,229.00 | transaction_form_type: 4 | Footnotes: F2, F5
    • Acquired 31,261 shares of Common Stock at $8.02 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: false | shares_owned_after: 38,490.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 31,261 shares of Common Stock at $170.38 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: false | shares_owned_after: 7,229.00 | transaction_form_type: 4 | Footnotes: F2, F6
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-05 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 7,344,500.00 | Footnotes: F7
    • Sold 78,703 shares of Stock Option (Right to Buy) at $171.28 per share (Derivative)
      Date: 2026-01-05 | Code: M | Expires: 2026-05-27 | Exercise: 2017-05-27 | equity_swap_involved: false | shares_owned_after: 93,121.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 29,450 shares of Stock Option (Right to Buy) at $172.33 per share (Derivative)
      Date: 2026-01-06 | Code: M | Expires: 2026-05-27 | Exercise: 2017-05-27 | equity_swap_involved: false | shares_owned_after: 63,671.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 31,261 shares of Stock Option (Right to Buy) at $170.38 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2026-05-27 | Exercise: 2017-05-27 | equity_swap_involved: false | shares_owned_after: 32,410.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options.
    • F2: Such transaction was pursuant to a pre-approved 10b5-1 plan.
    • F3: Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
    • F4: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $168.58 and $178.60.
    • F5: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $170.36 and $175.26.
    • F6: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $168.15 and $173.17.
    • F7: Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.

Search

News categories